Research and Development

Showing 15 posts of 9596 posts found.

Quotient buys Scottish clinical unit from Charles River

May 26, 2009 Research and Development Charles River, Quotient

Contract research organisation Quotient Bioresearch has acquired a facility from Charles River Laboratories that will boost its capabilities in the …

Phase III drug superior to Spiriva, says Novartis

May 21, 2009 Research and Development, Sales and Marketing COPD, Novarits

Novartis says its COPD treatment has shown significant benefits over two established rivals, and could form the cornerstone of a …

Mexican flu: contained but not beaten

May 21, 2009 Research and Development Mexico, Vaccine, flu, pandemic

Global efforts to limit the impact of the new strain of H1N1 flu virus have proven successful, but the threat …

Takeda to market new bone cancer drug

May 20, 2009 Research and Development, Sales and Marketing MA, Takeda

Takeda has gained the rights to the first treatment for a new malignant bone cancer affecting children and young adults. …

Cannabis-derived MS drug filed for European approval

May 20, 2009 Research and Development, Sales and Marketing GW, Sativex

Sativex, the cannabis-derived product developed by GW Pharmaceuticals, could be finally set for European approval after five years of delay. …

SkyePharma cuts staff at French and Swiss facilities

May 20, 2009 Research and Development, Sales and Marketing Skyepharma

SkyePharma has moved ahead with plans to cut its workforce at a manufacturing plant in France by a third as …

EFPIA plans counterfeit crackdown

May 20, 2009 Manufacturing and Production, Research and Development EFPIA, counterfeits

 European pharmaceutical industry association EFPIA has unveiled a new scheme to crack down on counterfeit medicines.Beginning with a trial run …

The medical-marketing interface and how to bridge the gap

May 18, 2009 Research and Development, Sales and Marketing marketing, medical

Drug companies are not charities and are accountable to their shareholders, as we all know. Products have to be sold …

GSK signs oncology deal with UK biotech

May 18, 2009 Research and Development, Sales and Marketing GSK, Oxford Biotherapeutics

GSK has struck a deal with Oxford BioTherapeutics to develop therapies for primary, metastatic and recurring forms of cancer. The …

Sanofi-Aventis signs deal with Japanese biotech

May 15, 2009 Research and Development, Sales and Marketing Sanofi-Aventis

Sanofi-Aventis has signed an early-stage research deal with biotech Kyowa Hakko Kirin, and will receive rights to its preclinical stage …

Kendle trims down as profits slump

May 15, 2009 Research and Development Kendle

Contract research organisation Kendle joined many of its peers in reporting a slump in demand for its clinical research services …

Boehringer signs diabetes and obesity deal

May 14, 2009 Research and Development, Sales and Marketing Boehringer

Boehringer Ingelheim has signed a deal with German biopharma firm DeveloGen to research and develop treatments for diabetes and obesity. …

Kennedy sets out views on NICE’s future

May 14, 2009 Research and Development NICE

Two stakeholder workshops which could shape NICE's future direction are to be held next week. Professor Sir Ian Kennedy has …

AstraZeneca buoyed as Brilinta tops Plavix in trial

May 13, 2009 Research and Development, Sales and Marketing AZ, Brillinta

AstraZeneca has been lifted by clinical results indicating its antiplatelet drug Brilinta outperformed Sanofi-Aventis/Bristol-Myers Squibb’s Plavix – currently the world’s …

UK a step closer to new swine flu vaccine

May 11, 2009 Research and Development NHS, h1n1

The first step towards producing a European prototype of a swine flu vaccine has been achieved by the UK's Health …
The Gateway to Local Adoption Series

Latest content